Navigation Links
PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
Date:9/24/2007

ANNAPOLIS, Md., Sept. 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: PIP), a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological terrorism, announced today the Department of Health and Human Services has published an award notice, dated September 21, 2007, in the amount of $13,920,347, listing PharmAthene as the contractor, relating to the development of therapeutic agents for selected bacterial diseases. PharmAthene has not received an executed agreement from the Department of Health and Human Services and expects to provide further information if and when such an executed agreement is received.

About PharmAthene, Inc.

PharmAthene (Amex: PIP) was formed to meet the critical needs of the United States and its Allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead programs include Valortim(TM) for the prevention and treatment of anthrax infection and Protexia(R) for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents. For more information on PharmAthene, please visit http://www.PharmAthene.com.


'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Bruce Maas named CIO at UW-Milwaukee
2. Three finalists named for UW-Madison CIO
3. Eight lawmakers named to Speakers IT task force
4. Hospital named for Madame Curie installs TomoTherapy system
5. Two UW-Madison professors named to National LambdaRail Networking Research Council
6. UW researcher named top innovator
7. Alzheimers drug firm and more winners named in Wisconsin business-plan contest
8. Inacom named Microsofts favorite learning solutions partner of the year
9. Five Wisconsin CIOs named top in nation
10. Deltanoid named to top-15 list of biotech companies
11. Venture Investors early-stage fund grows to $115 million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... July 20, 2017 , ... ... make clinical trial sites and study participants truly unified. TrialKit, a native mobile ... 21 CFR Part 11) research studies entirely on mobile devices. With TrialKit, clinical ...
(Date:7/18/2017)... ... ... G-CON today announced that it has received Notices of ... 14/858,857 and 13/669,785 both entitled Modular, Self-Contained, Mobile Clean Room. The U.S. Patent ... G-CON’s R&D investments and validate the G-CON platform as a novel way to ...
(Date:7/17/2017)... ... July 17, 2017 , ... ... device testing capabilities to encompass the full series of ISO 80369 standard test ... fittings for medical device and drug delivery systems. With this recent expansion, Whitehouse ...
(Date:7/17/2017)... ... July 17, 2017 , ... Neurodevelopmental disorders ... range of overlapping clinical features. The advancement of targeted next-generation sequencing (NGS) has ... research and testing. , However, designing a custom panel for disease research ...
Breaking Biology Technology:
(Date:5/16/2017)... 2017   Bridge Patient Portal , an ... MD EMR Systems , an electronic medical record ... have established a partnership to build an interface ... GE Centricity™ products, including Centricity Practice Solution (CPS), ... These new integrations will allow healthcare delivery networks ...
(Date:4/17/2017)... MELBOURNE, Florida , April 17, 2017 ... security technology company, announces the filing of its 2016 Annual Report ... Securities and Exchange Commission. ... Report on Form 10-K is available in the Investor Relations section ... well as on the SEC,s website at http://www.sec.gov . ...
(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
Breaking Biology News(10 mins):